Redmond Asset Management’s Evolent Health EVH Stock Holding History

Redmond Asset Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-70,671	Closed	-$562K	–	154
2019 Q2	$562K	Buy	70,671 +500	+0.7%	+$5.92K	0.24%	119
2019 Q1	$883K	Buy	70,171 +1,592	+2%	+$25.2K	0.38%	88
2018 Q4	$1.37M	Sell	68,579 -219	-0.3%	-$5.07K	0.65%	55
2018 Q3	$1.95M	Buy	68,798 +401	+0.6%	+$9.57K	0.77%	45
2018 Q2	$1.44M	Hold	68,397	–	–	0.61%	61
2018 Q1	$975K	Buy	68,397 +727	+1%	+$10.4K	0.43%	80
2017 Q4	$832K	Buy	67,670 +27,804	+70%	+$392K	0.36%	89
2017 Q3	$710K	Hold	39,866	–	–	0.32%	94
2017 Q2	$1.01M	Buy	39,866 +175	+0.4%	+$4.21K	0.48%	77
2017 Q1	$885K	Buy	39,691 +406	+1%	+$7.79K	0.45%	80
2016 Q4	$581K	Buy	+39,285	New	+$774K	0.27%	109

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Redmond Asset Management's EVH Position: Q3 2019 in Review

Redmond Asset Management sold out of Evolent Health (EVH) in Q3 2019, closing a stake of 70,671 shares — an estimated $562K sold.

Redmond Asset Management first reported a position in EVH in Q4 2016 and held it in 11 quarters. The position peaked at $1.95M in Q3 2018. 174 funds tracked by Wall St. Rank hold EVH as of Q3 2019.

Redmond Asset Management reported no remaining Evolent Health position as of Q3 2019 after selling out during the quarter.
Redmond Asset Management sold 70,671 Evolent Health shares in Q3 2019, an estimated $562K.
Redmond Asset Management first reported a position in Evolent Health in Q4 2016 and held it in 11 quarters.
Redmond Asset Management's Evolent Health position peaked at $1.95M in Q3 2018.
174 funds tracked by Wall St. Rank held Evolent Health as of Q3 2019.

Based on Redmond Asset Management's 13F filing for Q3 2019, filed 7 Nov 2019.